感染控制市場規模、佔有率和成長分析（按產品、應用、通路、最終用戶和地區分類）－2026-2033年產業預測

預計到 2024 年，全球感染控制市場規模將達到 481.7 億美元，到 2025 年將達到 512 億美元，到 2033 年將達到 834.8 億美元，預測期（2026-2033 年）的複合年成長率為 6.3%。

全球感染控制市場的主要驅動力是外科手術和醫療過程中對感染控制日益成長的需求，這對於獲得良好的臨床療效至關重要。醫療機構、製藥公司和醫療設備製造商對消毒滅菌的需求激增，而新冠疫情的爆發更是加劇了這一趨勢，顯著推動了市場擴張。消毒劑產量的大幅成長正是該領域產品創新的一個例子。滅菌技術的進步以及外包滅菌服務的日益普及進一步提升了市場潛力。此外，各國政府為加強感染預防通訊協定所採取的支持措施，以及世界衛生組織（WHO）等國際組織發布的全球指南，都在提高公眾意識，為有效的預防措施奠定基礎，並支持市場整體成長。

全球感染控制市場促進因素

醫療相關感染的日益增多是全球感染控制市場的主要促進因素。人們越來越意識到有效感染預防策略的重要性，也凸顯了這些感染每年對無數患者造成的影響。這種擔憂促使人們增加了在感染控制措施方面的支出，包括個人防護設備（PPE）、消毒劑和滅菌設備。醫療機構目前正採用整體感染控制方法，優先考慮病患安全和醫療品質。這導致對旨在降低感染風險和提高整體醫療服務品質的創新解決方案的需求不斷成長。

限制全球感染控制市場的因素

全球感染控制市場面臨諸多限制因素，其中之一便是採用先進技術的感染控制產品高成本。實施有效的感染控制策略通常需要對精密設備、持續維護和專業培訓進行大量投資。因此，小規模的醫療機構可能缺乏購買這些必要解決方案的資金，阻礙了其實施有效感染控制措施的能力。這種經濟負擔會阻礙整體市場成長，並限制創新產品和技術的應用。許多公司仍在努力應對如何在提供高品質感染控制解決方案的同時保持成本效益的挑戰。

全球感染控制市場趨勢

全球感染控制市場正呈現出顯著的趨勢，即整合包括自動化和數位化解決方案在內的高科技手段，以加強感染預防措施。醫療機構正日益採用智慧技術，例如自動化消毒系統和即時監控工具，從而簡化感染控制流程。這些創新不僅提高了營運效率，還有助於追蹤合規情況並識別需要改進的領域。將先進技術融入感染控制策略可望改善病患安全狀況，並提升醫療機構的整體營運效率，標誌著醫療環境正逐步朝向更智慧和反應迅速的方向轉變。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術分析
• 監管分析

全球感染控制市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 無菌產品
  • 熱力消毒器
  • 濕熱滅菌器
  • 乾熱滅菌器
  • 低溫滅菌器
  • 放射線殺菌
• 清潔和消毒產品
  • 消毒器
  • 清洗消毒器
  • 閃光消毒器
  • 其他
  • 內視鏡清潔系統
  • 高階內視鏡清洗系統
  • 中階端內視鏡清洗系統
  • 低階內視鏡清洗系統
• 個人防護屏障
• 內視鏡清潔產品
• 抗菌表面
• 其他感染控制產品

全球感染控制市場規模（依應用領域及複合年成長率分類）（2026-2033 年）

• 手術器械
• 內視鏡檢查
• 超音波探頭
• 其他

全球感染控制市場規模（按通路和複合年成長率分類）（2026-2033 年）

• 直接競標
• 零售
• 第三方經銷商

全球感染控制市場規模（按最終用戶和複合年成長率分類）（2026-2033 年）

• 醫院
• 診所
• 醫療設備製造商
• 製藥和生物技術公司
• 研究所
• 其他

全球感染控制市場規模（按地區分類）及複合年成長率（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• 3M Company（USA）
• Ecolab Inc.（USA）
• Getinge AB（Sweden）
• STERIS plc（Ireland）
• Fortive Corporation（USA）
• Cardinal Health, Inc.（USA）
• Medline Industries, LP（USA）
• Paul Hartmann AG（Germany）
• Becton, Dickinson and Company（BD）（USA）
• Johnson & Johnson（USA）
• MMM Group（Germany）
• Belimed AG（Switzerland）
• Envista Holdings Corporation（USA）
• SC Johnson Professional（USA）
• Reckitt Benckiser Group plc（UK）
• Gojo Industries, Inc.（USA）
• Diversey Holdings, Ltd.（USA）

結論與建議

Global Infection Control Market size was valued at USD 48.17 Billion in 2024 and is poised to grow from USD 51.2 Billion in 2025 to USD 83.48 Billion by 2033, growing at a CAGR of 6.3% during the forecast period (2026-2033).

The global infection control market is primarily driven by the increasing demand for infection management during surgical and therapeutic procedures, which is essential for achieving positive clinical outcomes. The surge in sterilization and disinfection requirements across healthcare facilities, pharmaceutical companies, and medical device manufacturers, exacerbated by the COVID-19 pandemic, has significantly contributed to market expansion. Substantial growth in sanitizer production exemplifies product innovation in this sector. Advancements in sterilization technologies and the growing trend of outsourcing sterilization services further boost market potential. Additionally, supportive government initiatives aimed at enhancing infection prevention protocols and global guidelines from organizations like the World Health Organization promote awareness, laying a foundation for effective preventive measures and fostering overall market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infection Control market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Infection Control Market Segments Analysis

Global Infection Control Market is segmented by Product, Application, Distribution Channel, End User and region. Based on Product, the market is segmented into Sterilization Products, Cleaning and Disinfection Products, Personal Protective Barriers, Endoscope Reprocessing Products, Anti-Microbial Surfaces and Other Infection Control Products. Based on Application, the market is segmented into Surgical Instruments, Endoscopes, Ultrasound Probes and Others. Based on Distribution Channel, the market is segmented into Direct Tender, Retail Sales and Third Party Distributors. Based on End User, the market is segmented into Hospitals, Clinics, Medical Device Companies,Pharmaceuticaland Biotechnology Companies, Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Infection Control Market

The growing prevalence of healthcare-associated infections serves as a significant driver in the global infection control market. The heightened awareness surrounding the necessity for effective infection prevention strategies highlights the impact these infections have on countless patients each year. This concern has led to increased expenditures on infection control measures, including personal protective equipment (PPE), disinfectants, and sterilization equipment. Healthcare organizations now adopt a comprehensive approach to infection control, prioritizing patient safety and the quality of care. Consequently, this has spurred demand for innovative solutions aimed at reducing infection risks and enhancing overall healthcare delivery.

Restraints in the Global Infection Control Market

The Global Infection Control market faces significant restraints due to the high costs associated with infection control products that utilize advanced technologies. Implementing effective infection control strategies often necessitates substantial investments in sophisticated equipment, ongoing maintenance, and specialized training. Consequently, smaller healthcare facilities may lack the financial resources to procure these essential solutions, which can undermine their ability to implement effective infection control measures. This financial burden can hinder overall market growth and limit the adoption of innovative products and technologies. Many companies continue to grapple with the challenge of delivering high-quality infection control solutions while maintaining cost-effectiveness.

Market Trends of the Global Infection Control Market

The Global Infection Control market is witnessing a significant trend towards the integration of high-tech advancements, including automation and digital solutions, to enhance infection prevention measures. Healthcare institutions increasingly adopt smart technologies such as automated disinfection systems and real-time monitoring tools, which streamline infection control processes. These innovations not only improve operational efficiency but also facilitate compliance tracking and identify areas for improvement. The incorporation of advanced technologies into infection control strategies is anticipated to transform patient safety outcomes and overall operational effectiveness in healthcare settings, signaling a progressive shift towards more intelligent and responsive healthcare environments.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis

Global Infection Control Market Size by Product & CAGR (2026-2033)

• Market Overview
• Sterilization Products
  • Heat Sterilization Equipment
  • Moist Heat Sterilization Equipment
  • Dry Heat Sterilization Equipment
  • Low-Temperature Sterilization Equipment
  • Radiation Sterilization Equipment
• Cleaning and Disinfection Products
  • Disinfector
  • Washer Disinfector
  • Flusher Disinfector
  • Others
  • Endoscopic Reprocessor Systems
  • High-End Endoscopic Reprocessor Systems
  • Mid-Range Endoscopic Reprocessor Systems
  • Low-End Endoscopic Reprocessor Systems
• Personal Protective Barriers
• Endoscope Reprocessing Products
• Anti-Microbial Surfaces
• Other Infection Control Products

Global Infection Control Market Size by Application & CAGR (2026-2033)

• Market Overview
• Surgical Instruments
• Endoscopes
• Ultrasound Probes
• Others

Global Infection Control Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Tender
• Retail Sales
• Third Party Distributors

Global Infection Control Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinics
• Medical Device Companies
• Pharmaceutical and Biotechnology Companies
• Laboratories
• Others

Global Infection Control Market Size & CAGR (2026-2033)

• North America (Product, Application, Distribution Channel, End User)
  • US
  • Canada
• Europe (Product, Application, Distribution Channel, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, Distribution Channel, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, Distribution Channel, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, Distribution Channel, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• 3M Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ecolab Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STERIS plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fortive Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medline Industries, LP (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Paul Hartmann AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MMM Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Belimed AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Envista Holdings Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SC Johnson Professional (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gojo Industries, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diversey Holdings, Ltd. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations